GWN Securities’s Edwards Lifesciences EW Stock Holding History

GWN Securities’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,525	Closed	-$658K	–	725
2024 Q4	$658K	Buy	+9,525	New	+$667K	0.18%	127

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GWN Securities's EW Position: Q1 2025 in Review

GWN Securities sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 9,525 shares — an estimated $658K sold.

GWN Securities first reported a position in EW in Q4 2024 and held it in 1 quarter. The position peaked at $658K in Q4 2024. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

GWN Securities reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
GWN Securities sold 9,525 Edwards Lifesciences shares in Q1 2025, an estimated $658K.
GWN Securities first reported a position in Edwards Lifesciences in Q4 2024 and held it in 1 quarter.
GWN Securities's Edwards Lifesciences position peaked at $658K in Q4 2024.
1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on GWN Securities's 13F filing for Q1 2025, filed 15 May 2025.